"当院は京都市西部、乙訓地域、京都中部地域の約70万人の人口圏にある基幹病院であり、その地域で最大の病床数を誇ります。 高度ながん医療に対応するため高精度の放射線治療装置や手術支援ロボット、ダ・ヴィンチも導入して多くの治療が行われ、がんゲノム医療連携病院にも指定されています。 2020年度は救急車の搬入件数が3987台となりました。地域の方が心筋梗塞などの循環器の疾患、脳卒中などの脳神経の疾患、吐血・下血などの消化器の疾患、呼吸困難や喀血などの呼吸器の疾患、その他、急病になられた時に頼りにされる病院を目指してゆきたいと考えております。"

During the past decade, Kyoto Katsura Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyoto Katsura Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored, "Japan Multinational Trial Organization" with 2 trials sponsored and "Kyoto University" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyoto Katsura Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Alpha-A, Inc." with 1 trials as a collaborator, "Guidant Corporation" with 1 trials as a collaborator, "Medtronic Japan Co., Ltd." with 1 trials as a collaborator and "NPO International TRI Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Kyoto Katsura Hospital" are "Coronary Artery Disease" (4 trials), "Colorectal Neoplasms" (2 trials), "Pyruvate Kinase Deficiency" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Anemia, Hemolytic" (1 trials). Many other conditions were trialed in "Kyoto Katsura Hospital" in a lesser frequency.

Most popular intervention types in "Kyoto Katsura Hospital" are "Drug" (9 trials), "Device" (6 trials), "Procedure" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG-348" (2 trials), "Placebo" (2 trials), "adjuvant therapy" (2 trials), "cisplatin" (2 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto Katsura Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Kyoto Katsura Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kyoto Katsura Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto Katsura Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".